ENLIGHT

Funded by the EU H2020, ENLIGHT researchers will develop a living model of the pancreas to enable better testing of diabetes medication. This model is manufactured using a new method of bioprinting invented at the UMC Utrecht and EPFL (École polytechnique fédérale de Lausanne), and specialized stem cells studied by ETH Zürich and the University of Naples Federico II Project Coordinator: Riccardo Levato: “With eight European partners, we will now develop a new bioprinter that, using visible light, prints stem cells three-dimensionally into functional pancreatic tissues.” ENLIGHT has received a 4-year grant from the European innovation Council fund Horizon 2020 under grant agreement 945119. The aim is to realize the first working tissue model within three years. Read more about the project here: https://lnkd.in/gbpuVXi